CD37 and diffuse large B-cell lymphoma: Accordingly, Arribas et al. generated two DLBCL cell line models (SU-DHL-2 and SU-DHL-4), which were resistant to IMGN529/DEBIO1562 (an anti-CD37 ADC) and demonstrated different phenotypic changes within the models [74].